Introduction
Timely follow-up visits after psychiatric hospitalization are considered an important component in the clinical process for promoting further recovery and preventing relapse (Hermann et al., 2004) .
However, it remains unclear whether timely follow-up visits after psychiatric hospitalization are associated with a reduced risk of readmission (Beadles et al., 2015; Kurdyak et al., 2018; Lin and Lee, 2008; Marcus et al., 2017) .
A cohort study of 24,934 Medicaid patients, aged 22-64 years, reported no association between follow-up visits within 30-days after discharge and readmission within the subsequent 6-months in a depression cohort and a small association in a schizophrenia cohort (Beadles et al., 2015) . A recent cohort study of 71,776 commercially and Medicaid insured patients, aged 18-64 years, showed that receipt of a follow-up visit within 30 days after discharge was associated with slightly lower odds of readmission within the subsequent 90 days in schizophrenia (odds ratio [OR] , 0.88) and in bipolar (OR, 0.91) cohorts (Marcus et al., 2017) . A recent cohort study of 19,132 patients with schizophrenia in Canada also found small associations (hazard ratio, 0.83-0.88) between follow-up visits within 30 days after discharge and readmissions within the subsequent 180 days (Kurdyak et al., 2018) . However, a cohort study of 15,607 patients with schizophrenia in Taiwan found strong associations between follow-up visits within 60 days after discharge and readmission within the subsequent 120 (OR, 0.33) days after discharge (Lin and Lee, 2008) .
Thus, the strength of the association between timely follow-up visits after discharge and subsequent readmission may vary by diagnosis and country. In the present study, we aimed to ACCEPTED MANUSCRIPT
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Methods

Design
A retrospective cohort study was conducted using the National Database of Health Insurance
Claims and Specific Health Checkups of Japan (NDB). The NDB includes almost all claims in Japan (Ministry of Health, Labour and Welfare, 2016; Okumura et al., 2017) , with the exception of claims solely covered by public funds. The NDB includes information on patient identification number, sex, and age group, along with medical practice codes, administration dates, and diagnostic codes.
The institutional review board at the Institute for Health Economics and Policy reviewed and approved the study protocol. Acquisition of informed consent was waived because of the anonymous nature of the data.
Setting
Japan has had a universal healthcare system since 1961. Japan had 330,694 psychiatric beds in 1,599 hospitals in 2014 (Ministry of Health, Labour and Welfare and National Center of Neurology and Psychiatry, 2016) . Hospitals with psychiatric beds are mainly private hospitals rather than public ones.
There is no obligation for the hospitals to follow-up patients after discharge. In general, the universal health insurance system pays for 70% of the outpatient treatment costs, the System of Medical Payment for Services and Supports for Persons with Disabilities pays for approximate 20%, and patients are responsible for the remaining amount (approximately 10%).
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Patient selection
We identified all patients aged <65 years who were admitted to any psychiatric unit between April 2014 and March 2015. The psychiatric units included in the present study are presented in Table S1 . To increase traceability, we used patient identification numbers, called "ID0" (Kubo et al., 2018 Patients with a secondary diagnosis of dementia (F00-F03, F05.1, and G30-G31) or intellectual disability (F70-F79) in addition to the principal diagnosis of schizophrenia or bipolar disorder were excluded.
Patients hospitalized for longer than 180 days were excluded as including these patients would have meant that some patients would not have the required follow-up period of 210 days. Patients discharged to a non-psychiatric unit or deceased were excluded. Patients who enrolled in the database at least 180 days before the index admission and 210 days after the index discharge were included. Patients admitted to any type of hospital unit within 30 days after the index discharge were excluded because of the time window for the exposure status. All patients were followed up from 180 days before the index admission to 210 days after the index discharge.
Exposure
The exposure of interest was a timely follow-up visit to a psychiatrist. A timely follow-up visit was defined as an outpatient visit to a psychiatrist within 30 days after the index discharge (the medical practice codes for psychiatric visits are listed in Table S2 ). Our definition of follow-up visit included passive outpatient visits as well as home-visit services by psychiatrists. In addition, the definition
included psychiatric consultation for at least 5 minutes delivered in an individual-based format rather than a group-based format.
Outcomes
The primary outcome of this study was psychiatric readmission during the 180-day period (between 31 and 210 days) after the index discharge. The secondary outcome was psychiatric readmission during the 90-day period (between 31 and 120 days) after the index discharge. Planned readmissions for electroconvulsive therapy were excluded from the definition of psychiatric readmission.
Other variables
As potential covariates, we extracted information on patient demographic characteristics (sex and of index admissions (type of hospital, unit, and admission; principal diagnosis, use of electroconvulsive therapy, and length of stay). These covariates were selected based on evidence derived from previous studies (Beadles et al., 2015; Kurdyak et al., 2018; Lin and Lee, 2008; Marcus et al., 2017) .
The type of hospital was classified as either general or non-general; general hospitals have ≥100 beds with at least the following five specialties: internal medicine, surgery, obstetrics and gynecology, otolaryngology, and ophthalmology. The type of unit was classified as either acute care or non-acute care; acute care units were defined as the eight types of psychiatric units listed in Table S1 . The type of admission was classified as either voluntary or involuntary.
Statistical analyses
First, we assessed covariate balance using standardized differences, in which an absolute value greater than 10% indicates an important imbalance in the prevalence of a covariate between the groups (Austin, 2011) . Second, we fitted a Poisson regression model and compared risks between the groups.
All potential covariates were simultaneously entered into the models. Risk ratios (RR) and their 95%
confidence intervals (CI) were derived from the model. Third, we conducted a subgroup analysis to examine whether the association varied across the levels of all covariates. We assessed the statistical significance of interaction terms with a significance level of 0.05. Fourth, we conducted a sensitivity analysis using a propensity matching method. We estimated propensity scores by using a logistic regression model with the following algorithm: nearest neighbor matching method, matching ratio of 1:1, caliper width of 0.2 of the standard deviation of the logit of the propensity score, and no replacement (Austin, 2011) . Within the propensity score matched cohort, we used the method of Agresti and Min to compare readmission rates (Agresti and Min, 2004) . Fifth, we conducted sensitivity analyses based on another time frame in which a timely follow-up visit was defined as an outpatient visit to a psychiatrist within 60 days after the index discharge, and outcomes were defined as psychiatric readmissions during the 180-day period (between 61 and 240 days) and the 90-day period (between 61 and 150 days) after the index discharge. Statistical analyses were performed using R version 3.4.1 (R Foundation for Statistical
Computing, Vienna, Austria) with the MatchIt package.
Results
Study population
The study cohort included 48,579 patients (Fig. S1 ). Among these, 7,246 patients (14.9%) had no (Table 1) .
Main analyses
Patients who received timely follow-up visits had lower readmission rates during the 180-day Fig. 1; Fig. 2 ).
Subgroup analysis showed that the strength of the associations was modified by several factors, although the direction of the associations did not vary by subgroup. For example, the strength of the association was weaker among patients with a history of psychiatric admissions (adjusted RR, 0.70) than among those without (adjusted RR, 0.50) (Fig. 1) . The strength of the association was similar among patients with bipolar disorder and those with schizophrenia ( Fig. 1) . Similar findings were observed in the secondary outcome results (Fig. 2) .
Sensitivity analyses
We identified a propensity score-matched cohort of 14,454 patients from the entire cohort (Table   2 ; Table S3 ). The covariate balance was considerably improved ( (Table S4 ). The strength of the association between follow-up visits and readmission was weaker when follow-up visits were defined as ≤ 60 days rather than ≤ 30 days (Table S4; Table S5 ).
Discussion
Our study found a moderate association between timely follow-up visits after psychiatric hospitalization and risk of readmission in patients with schizophrenia or bipolar disorder using the ACCEPTED MANUSCRIPT
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12 nationwide claims database. The strength of this association appears to be much higher in Japan than in the United States and Canada (Kurdyak et al., 2018; Marcus et al., 2017) , although the risk of readmission in patients receiving follow-up visits was similar in Japan (180-day readmission rate: 22%; 90-day readmission rate: 12%) and in the United States (90-day readmission rate: 10%-13%) and Canada (180-day readmission rate: 22%). Follow-up rates after psychiatric hospitalization and baseline risk of readmission (i.e., risk of readmission in patients receiving no follow-up visits) might mutually influence the strength of the association between timely follow-up visits and readmission. Patients with no follow-up visits who are living in a country with high follow-up rates are likely to have a higher risk of readmission than those living in a country with low follow-up rates.
We found that the follow-up rate within 30 days after psychiatric hospitalization was 85%, which was much higher than that reported in previous studies. For example, Marcus et al. reported that the 30-day follow-up rate was 64%-65% in a schizophrenia cohort and 62%-73% in a bipolar cohort of commercially and Medicaid insured adults (Marcus et al., 2017) . Fontanella et al. also found that the 30-day follow-up rate was 70% in a mood disorder cohort of Medicaid enrolled youth (Fontanella et al., 2016) . Kurdyak et al. reported that the 30-day follow-up rate for psychiatrists or primary care physicians was 65% in a schizophrenia cohort of Canadian adults (Kurdyak et al., 2018) .
The baseline risk of readmission within the subsequent 180 days was higher in our study (38%) than that reported by Kurdyak et al. (26%) (Kurdyak et al., 2018) . Similarly, the baseline risk of readmission within the subsequent 90 days was also much higher in our study (29%) than that reported by Marcus et al. (13% in schizophrenia and 11% in bipolar cohorts) (Marcus et al., 2017) .
Our study has several limitations. First, we could not measure important potential covariates, such as history of suicide attempts, financial status, marital status, education level, patient satisfaction with treatment, insight into illness, and type of discharge (e.g., discharge on/against medical advice) (Donisi 13 et al., 2016) . For example, patients who have better insight into their illness are more likely to receive follow-up visits and to have better adherence to medications. As a result, those patients might have lower risk of readmission. Future studies are needed to confirm the balance pertaining to these unmeasured covariates between the groups. Second, our data did not include claims solely covered by public funds, comprising approximately 19% of psychiatric discharges (Niimura et al., 2017) . Third, our data could not exclude healthy-user bias because we focused only on patients who were discharged to the community within 180 days after admission and those who enrolled in the database at least 210 days after discharge. Fourth, we could conduct subgroup analyses by diagnostic subtype (i.e., manic, depressed, or mixed episode) due to concerns about coding accuracy. Fifth, we focused on limited aspects of the exposures and outcomes. It would be valuable to further investigate the effectiveness of timely follow-up visits on the risk for readmission in the short term (e.g., within 30 days after discharge)
as well as in the long term (e.g., 360 days after discharge). In addition, studies are needed to determine the comparative effectiveness of type of follow-up visits with consideration of the costs and benefits.
Sixth, the generalizability of our findings is uncertain because healthcare system structure differs among countries and it may influence the follow-up and readmission rates.
Nevertheless, our findings suggest that 15% of discharged patients with schizophrenia or bipolar disorder do not receive timely follow-up visits to a psychiatrist. These patients are at higher risk of psychiatric readmission. Therefore, timely follow-up visits after discharge could be helpful for reducing the readmission risk in patients. A C C E P T E D M A N U S C R I P T A C C E P T E D M A N U S C R I P T 
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